<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[vfc's stock house Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/vfc%27s+stock+house.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to vfc's stock house]]></description>
	<s:counts start="0" returned="20" found="137" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Sunesis Pharma's Impressive Gain: Hoping for a Dip]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177730-sunesis-pharma-s-impressive-gain-hoping-for-a-dip%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Sunesis Pharmaceuticals, Inc. SNSS rallied Thursday on an impressive run that saw the stock reach an intra-day high of $1.84, a full 131% price increase from the open. Earlier in the week, SNSS moved higher on news that the company's lead drug Voreloxin had proved...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 11 Dec 2009 02:42:24 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/sunesis+pharmaceuticals+inc..html"><![CDATA[Sunesis Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNSS</category>
		<category domain="tickers">SNSS</category>
	</item>
	<item>
		<title><![CDATA[All Eyes on Cel-Sci: Will Wednesday's Surge Continue?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177466-all-eyes-on-cel-sci-will-wednesday-s-surge-continue%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  With a late day surge of nearly twenty cents on Wednesday, Cel-Sci CVM will be a stock to watch during Thursday's trading. Investors will be looking for indications of whether or not the move was for real, and marking the end of the recent downtrend.With a late...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 09 Dec 2009 11:56:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/cel-sci+corp..html"><![CDATA[CEL-SCI Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
		<category domain="tickers">CVM</category>
	</item>
	<item>
		<title><![CDATA[Trading Stocks on Pink Sheets Should Not Be Ignored]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177059-trading-stocks-on-pink-sheets-should-not-be-ignored%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  An anonymous comment:   VFC,  Here is a tip for all your readers. Though I know there is money to be made on penny stocks, the pink markets are shady and underhanded. Other people are controlling YOUR money for THEIR interests. For example, the daily...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 08 Dec 2009 03:11:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
	</item>
	<item>
		<title><![CDATA[SIGA: Thursday's Drop Was Nothing But a Tree Shake]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176499-siga-thursday-s-drop-was-nothing-but-a-tree-shake%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of SIGA Technologies SIGA, Inc. traded down by over three percent on Thursday in what I consider to be more of a 'tree shake' than any kind of sell-off. Investors are still expecting an announcement any day regarding a possible BARDA small pox contract, and impatient...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 11:00:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/siga+technologies+inc..html"><![CDATA[SIGA Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SIGA</category>
		<category domain="tickers">SIGA</category>
	</item>
	<item>
		<title><![CDATA[SIGA: Interesting Stock to Watch Nowadays]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176199-siga-interesting-stock-to-watch-nowadays%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of SIGA Technologies SIGA enjoyed a nice run of late, reaching a high of ten dollars on Monday morning before profit takers and possible short sellers took the share price back down to below the nine dollar level. December call options have also performed brilliantly lately...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 10:22:46 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/siga+technologies+inc..html"><![CDATA[SIGA Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SIGA</category>
		<category domain="tickers">SIGA</category>
	</item>
	<item>
		<title><![CDATA[Titan Pharmaceutical: More Likely Buyout Target as Patent Protection Is Approved]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176196-titan-pharmaceutical-more-likely-buyout-target-as-patent-protection-is-approved%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Titan Pharmaceuticals (TTNP.PK) announced on Monday that the company had received confirmation from the United States Patent and Trademark Office [USPTO] that a Notice of Allowance had been issued for Probuphine for the treatment of Opiate addiction. This news has been long awaited and heavily anticipated by...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 10:12:33 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
	</item>
	<item>
		<title><![CDATA[Short Covering on Siga's Big News Makes for Happy Holidays]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175197-short-covering-on-siga-s-big-news-makes-for-happy-holidays%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Siga Technologies, Inc. SIGA broke the eight dollar mark Tuesday afternoon on anticipation of the possibility that some big government orders could be imminent. BioMedReports issued a mid-day trade alert on Tuesday, alerting readers that the recent price action of the SIGA stock could indicate...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 25 Nov 2009 12:19:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/siga+technologies+inc..html"><![CDATA[SIGA Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SIGA</category>
		<category domain="tickers">SIGA</category>
	</item>
	<item>
		<title><![CDATA[Holiday Cheer: Cel-Sci Should Have Good News]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175277-holiday-cheer-cel-sci-should-have-good-news%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Cel Sci Corp. CVM continued to hover right around the $1.30 mark even after TheStreet.com's infamous biotech blogger thrust his most recent blogging salvo at Cel Sci in an attempt to keep his ongoing vendetta against the company alive - for reasons that are still...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 25 Nov 2009 05:06:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/cel-sci+corp..html"><![CDATA[CEL-SCI Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
		<category domain="tickers">CVM</category>
	</item>
	<item>
		<title><![CDATA[Titan Pharmaceuticals: Finally Reaching Its Potential]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173912-titan-pharmaceuticals-finally-reaching-its-potential%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  It was a quick rise to the $2.40 level for shares of Titan Pharmaceuticals (TTNP.PK), as it finally looks like the stock is starting to trade towards its potential. With the heavyweight Novartis NVS set to commercially launch Fanapt early next year, the schizophrenia drug could quickly...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 17 Nov 2009 02:02:33 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Playing the Options Game in RIM; Cel Sci Not Yet Trading to Its Potential]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173476-playing-the-options-game-in-rim-cel-sci-not-yet-trading-to-its-potential%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  In "Readers Respond" I do my best to answer readers' questions, but keep in mind that my responses to these questions are my opinions and personal speculation that I have based on my own research and due diligence.  Also, I will try to respond to a...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 16 Nov 2009 01:29:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/gadgets.html"><![CDATA[Gadgets]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/cel-sci+corp..html"><![CDATA[CEL-SCI Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/research+in+motion+ltd..html"><![CDATA[Research In Motion Ltd.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
		<category domain="tickers">CVM,RIMM</category>
	</item>
	<item>
		<title><![CDATA[Don't Like Celsius Holdings? Try Cel-Sci Instead]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173461-don-t-like-celsius-holdings-try-cel-sci-instead%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  A comment from Scott regarding Celsius Holdings (CSUH.OB):  You tell a nice warm story about Carl being the big dog and you waiting under the table at dinner time, but the numbers and profitablity win in the end. And you're brushing off the basic financial landscape....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 15 Nov 2009 11:58:41 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/retail.html"><![CDATA[Retail]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/cel-sci+corp..html"><![CDATA[CEL-SCI Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
		<category domain="tickers">CVM</category>
	</item>
	<item>
		<title><![CDATA[Lexicon Pharmaceuticals: Stuck in Phase II?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172707-lexicon-pharmaceuticals-stuck-in-phase-ii%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Hi Vinny, I am a loyal follower and respect your opinion. I too am a long-term shareholder of CVM and see the potential of the company. That said, I wanted your opinion on two companies, of which I am already a shareholder, Lexicon Pharmaceuticals LXRX and Rexahn...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 11 Nov 2009 02:07:29 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/lexicon+pharmaceuticals+inc..html"><![CDATA[Lexicon Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LXRX</category>
		<category domain="tickers">LXRX</category>
	</item>
	<item>
		<title><![CDATA[Cel-Sci: Good News Could Lead to Long-Term Growth]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172507-cel-sci-good-news-could-lead-to-long-term-growth%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  As shares of Cel-Sci Corp. CVM have traded to the upside of late, the company is set to gain more exposure when it presents at the "7th Annual Vaccines: All Things Considered Conference" in Washington, DC on Tuesday afternoon. While I don't expect the Cel-Sci stock to...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 10 Nov 2009 07:54:44 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/cel-sci+corp..html"><![CDATA[CEL-SCI Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
		<category domain="tickers">CVM</category>
	</item>
	<item>
		<title><![CDATA[Titan Pharmaceuticals: The Future Looks Bright]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172625-titan-pharmaceuticals-the-future-looks-bright%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Titan Pharmaceuticals (TTNP.PK) dropped to the $1.81 level during early trading on Tuesday in what could be considered an attempt to 'shake' a few more shares loose - considering the fact that volume was nearing a stand still at the $1.90 level. With Fanapt royalties...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 10 Nov 2009 01:43:50 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
	</item>
	<item>
		<title><![CDATA[Cel-Sci, Johns Hopkins Move Forward With LEAPS]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172111-cel-sci-johns-hopkins-move-forward-with-leaps%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shortly after the market open on Friday, Cel-Sci Corp. CVM issued a press release declaring that the company will commence a Clinical Study measuring the effectiveness of the company's LEAPS technology in the treatment of H1N1-hospitalized patients. According to the press release, blood will be drawn from...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 08 Nov 2009 08:54:50 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/cel-sci+corp..html"><![CDATA[CEL-SCI Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
		<category domain="tickers">CVM</category>
	</item>
	<item>
		<title><![CDATA[Celsius in Southern California: A Logical Next Step]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172110-celsius-in-southern-california-a-logical-next-step%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  It was announced by Celsius Holdings (CSUH.OB) in a Thursday morning press release that the Celsius calorie burning beverage will soon be available in Ralph's Supermarkets in Southern California. The product is already entrenched in the NorthEastern portion of the country and a significant push into the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 08 Nov 2009 08:46:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/retail.html"><![CDATA[Retail]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
	</item>
	<item>
		<title><![CDATA[Sirius XM: Not Completely Out of the Woods Yet]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F171732-sirius-xm-not-completely-out-of-the-woods-yet%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Sirius XM SIRI satellite radio responded positively to news that losses narrowed and revenues increased during the third quarter of 2009. Aside from one time charges, the company reported cash flow break even.While I am confident in the ability of Sirius XM to continue demonstrating...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 05 Nov 2009 11:36:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/media.html"><![CDATA[Media]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/sirius+satellite+radio+inc..html"><![CDATA[Sirius Satellite Radio Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sirius.html"><![CDATA[Sirius]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SIRI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SIRI</category>
		<category domain="tickers">SIRI,SIRI</category>
	</item>
	<item>
		<title><![CDATA[Hemispherx Biopharma Could Become a Nice Rebound Story]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F171454-hemispherx-biopharma-could-become-a-nice-rebound-story%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Hemispherx Biopharma, Inc. HEB rebounded slightly on Wednesday morning after sliding down to near the one dollar mark on Tuesday after it was announced that the company would spend the next two months responding to FDA queries regarding the company's New Drug Application for Ampligen....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 05 Nov 2009 04:41:50 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/hemispherx+biopharma+inc..html"><![CDATA[Hemispherx BioPharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HEB</category>
		<category domain="tickers">HEB</category>
	</item>
	<item>
		<title><![CDATA[Titan Pharma Stock Remains Primed to Spike]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F170814-titan-pharma-stock-remains-primed-to-spike%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Titan Pharmaceuticals (TTNP.PK) was mentioned in a weekend article by the Washington Post that highlighted the CEO of Vanda Pharmaceuticals, Mihael Polymeropoulos, and Fanapt - Vanda's recently approved drug to treat schizophrenia of which Titan will reap up to 10% in royalties.While Novartis NVS emerged as Vanda's...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 03 Nov 2009 05:51:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/vanda+pharmaceuticals+inc..html"><![CDATA[Vanda Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VNDA</category>
		<category domain="tickers">VNDA</category>
	</item>
	<item>
		<title><![CDATA[Dendreon's Provenge Looks Likely to Be Approved in Mid-2010]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F170813-dendreon-s-provenge-looks-likely-to-be-approved-in-mid-2010%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Dendreon DNDN traded as much as five percent higher on Monday morning after the company announced that it has re-submitted its application for the regulatory approval of Provenge, a therapeutic prostate cancer vaccine that was called 'approvable' by the FDA in 2007. According to the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 03 Nov 2009 05:48:21 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon+corp..html"><![CDATA[Dendreon Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
		<category domain="tickers">DNDN</category>
	</item>
</channel>
</rss>
